MagtraceTM and Sentimag(R) Magnetic Locatization System
FDA premarket approval P160053 · decided 2018-07-24
Approval details
- PMA number
- P160053
- Trade name
- MagtraceTM and Sentimag(R) Magnetic Locatization System
- Generic name
- Lymph node location system during sentinel biopsy procedure
- Applicant
- Endomagnetics Ltd.,
- Date received
- 2016-11-30
- Decision date
- 2018-07-24
- Days to decision
- 601 days
- Decision code
- APPR
- Product code
- PUV
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Cambridge
- Statement
- Approval for the MagtraceTM and Sentimag® Magnetic Localization System. The MagtraceTM and Sentimag® Magnetic Localization System is indicated to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy. MagtraceTM is intended and calibrated for use ONLY with the Sentimag® system.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Magseed Pro Magnetic Marker System (K232865) | Endomagnetics Ltd., | 2024-06-28 |
| Sentimag System (K222832) | Endomagnetics Ltd., | 2023-01-21 |
| Magseed Magnetic Marker Systtem (K173587) | Endomagnetics Ltd., | 2018-02-16 |
| Magseed Magnetic Marker System (K163541) | Endomagnetics Ltd., | 2017-01-13 |
| Sentimag System, Sentimark Magnetic Marker Systerm (K153044) | Endomagnetics Ltd., | 2016-03-02 |